3D Cell Culture for Drug Discovery and Development: Market Outlook

https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

The 3D cell culture market is estimated to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. The growth of this market is mainly driven increasing adoption of 3D cell culture over 2D cell culture and rising demand for personalized medicine across the globe.

The prominent players operating in the 3D cell culture market are include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), and Avantor Inc. (US).